CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer
CombiCoR-Vax试验：一项II期、单臂、多中心试验的研究方案，该试验旨在评估帕博利珠单抗联合树突状细胞疫苗序贯治疗，随后使用三氟尿苷/替吡嘧啶和贝伐珠单抗治疗难治性微卫星稳定型转移性结直肠癌的疗效。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15371-7
Passardi, Alessandro; Sullo, Francesco Giulio; Bittoni, Alessandro; Matteucci, Laura; De Rosa, Francesco; Bulgarelli, Jenny; Tazzari, Marcella; Petrini, Massimiliano; Scarpi, Emanuela; Testoni, Sara; Miserocchi, Anna; Tartagni, Ottavia; Zani, Chiara; Iaia, Maria Laura; Toma, Ilaria; Viola, Massimo Giuseppe; Mita, Maria Teresa; Tamburini, Emiliano; Ridolfi, Laura
肿瘤
肠癌
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌
